Thyroid Cancer: Disease and Pipeline Analysis

ISR reports Thyroid Cancer is the most rapidly increasing cancer in the U.S. with 62,980 new cases predicted in 2014. Thyroid cancer forms in the thyroid gland, a butterfly shaped gland in the front part of the neck. 298,000 diagnosed cases per year, roughly the population of Lexington, KY. In the US, the incidence of thyroid cancer has been increasing at an average rate of 6.4% each year. The US, followed by China, has the highest number of new cases of thyroid cancer per year, globally. Common Types Types of thyroid cancer % of thyroid cancer cases Papillary 75-85% Follicular 10-15% Hürthle cell carcinoma 3% Poorly Differentiated Thyroid Carcinoma 1-6% 5% Medullary Anaplastic 1-2% Risk Factors radiation diet low in iodine hereditary conditions family history Pơ 40+ gender and age Nearly 2/3 of cases of thyroid cancer are found in people younger than 55 years of age. Women are three times more likely to develop thyroid cancer. Symptoms There are often physical signs of thyroid cancer present such as lumps, swelling, or nodules. Other symptoms of thyroid cancer only tend to occur after the condition has reached an advanced stage: • neck pain, voice changes, • persistent cough, • difficulty breathing, • dysphagia (difficulty swallowing) Treatment radioactive iodine treatment surgery External Beam chemotherapy Radiation targeted therapy thyroid hormone therapy Prognosis The prognosis of patients diagnosed with thyroid cancer varies according to both the type of thyroid cancer and the stage of the disease at diagnosis. For all thyroid tumor types diagnosed at stage I or II, prognosis is excellent, with 5 year survival approaching 100%. Five year survival rate (papillary thyroid cancer): 97.8% 90% 50% Stage I or II Stage II Stage IV Future Development Recent approvals for the targeted therapies have provided treatment options for patients with advanced and aggressive thyroid cancers who would otherwise have only palliative care options available to them. Currently, there are 91 40,283 Clinical Trials Patients Learn more in ISR's Thyroid Cancer: Disease and Pipeline Analysis. ISR Sources: ISR reports, cancer.org, seer.cancer.gov, clinicaltrials.gov reports